Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Sandoz CEO Saynor Signals No Change To Focus Amid Strategic Review
Novartis Unit’s Strategy Remains Unaltered As Parent Company Explores All Options
Nov 05 2021
•
By
David Wallace
Richard Saynor says it is still ‘business as usual’ for Sandoz • Source: Sandoz
More from Strategy
More from Business